Psychosocial interventions for depression and anxiety in Parkinson's disease

Journal of Geriatric Psychiatry and Neurology

Volumn 25, Issue 2, 2012, Pages 113-121

  Yang, Sarah ^a   Sajatovic, Martha ^a   Walter, Benjamin L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

behavioral therapy; depression; Parkinson's disease; psychosocial treatment

Indexed keywords

ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DEPRESSION; GROUP THERAPY; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHODRAMA; PSYCHOEDUCATION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; SAMPLE SIZE; STRESS MANAGEMENT; SYSTEMATIC REVIEW;

ANXIETY; COGNITIVE THERAPY; DEPRESSION; HUMANS; PARKINSON DISEASE; PSYCHOTHERAPY, GROUP;

EID: 84862252570     PISSN: 08919887     EISSN: 15525708     Source Type: Journal    
DOI: 10.1177/0891988712445096     Document Type: Article

References (40)

1. Reijnders JS, Ehrt U, WeberWE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23(2):183-189; quiz 313.
2. Weintraub D, Moberg PJ, Duda JE, et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc. 2004;52(5):784-788. (Pubitemid 38596500)
3. Ravina B, Camicioli R, Como PG, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69(4): 342-347. (Pubitemid 47205660)
4. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci. 2006;248(1-2):151-157. (Pubitemid 44647306)
5. Hart L, Middleton RK, Wandres DL. Depression treatment in Parkinson's disease. DICP. The Annals of Pharmacotherapy. 1991;25(2):137-138.
6. Ghazi-Noori S, Chung TH, Deane K, Rickards HE, Clarke CE . Therapies for depression in Parkinson's disease. Cochrane Database of Systematic Reviews. 2003.
7. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry. 1992;149(4):443-454.
8. Menza M, Dobkin RD, Marin H, et al. The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. Mov Disord. 2009;24(9):1325-1332.
9. Weintraub D, Morales KH, Moberg PJ, et al. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Mov Disord. 2005;20(9):1161-1169. (Pubitemid 41632203)
10. Althaus A, Becker OA, Spottke A, et al. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord. 2008;14(8):626-632.
11. Rickards H. Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. J Neurol, Neurosurg Psychiatry. 2005;76(suppl 1):i48-i52. (Pubitemid 40293043)
12. Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2005;17(3):310-323. (Pubitemid 46179293)
13. Wood LD, Neumiller JJ, Setter SM, et al. Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease. Am J Geriatr Pharmacother. 2010;8(4):294-315.
14. van de Vijver DA, Roos RA, Jansen PA, Porsius AJ, de Boer A. Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. Br J Clin Pharmacol. 2002;54(2):168-170. (Pubitemid 35024940)
15. Vajda FJ, Solinas C. Current approaches to management of depression in Parkinson's disease. J Clin Neurosci. 2005;12(7):739-743. (Pubitemid 41411876)
16. National Alliance on Mental Illness. National alliance on mental illness (NAMI). http://www.nami.org.
17. American Psychiatric Association, ed. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed. Arlington, VA: American Psychiatric Association; 2010.
18. Ayers CR, Sorrell JT, Thorp SR, Wetherell JL. Evidence-based psychological treatments for late-life anxiety. Psychol Aging. 2007;22(1):8-17. (Pubitemid 46494612)
19. Farabaugh A, Locascio JJ, Yap L, et al. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 2010;51(2):124-129.
20. Trend P,Kaye J,Gage H,OwenC,Wade D.Short-termeffectiveness of intensive multidisciplinary rehabilitation for people with Parkinson's disease and their carers. Clin Rehabil. 2002;16(7):717-725. (Pubitemid 35276571)
21. Wade DT, Gage H, Owen C, Trend P, Grossmith C, Kaye J. Multidisciplinary rehabilitation for people with Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry. 2003;74(2):158-162. (Pubitemid 36160673)
22. Dobkin RD, Menza M, Allen LA, et al. Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. Am J Psychiatry. 2011;168(10):1066-1074.
23. Dobkin RD, Allen LA, Menza M. Cognitive-behavioral therapy for depression in Parkinson's disease: a pilot study. Mov Disord. 2007;22(7):946-952. (Pubitemid 46999289)
24. Veazey C, Cook KF, Stanley M, et al. Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson's disease. J Clin Psychol Med Settings. 2009; 16(3):243-253.
25. Sproesser E, Viana MA, Quagliato EM, et al. The effect of psychotherapy in patients with PD: a controlled study. Parkinsonism Relat Disord. 2010;16(4):298-300.
26. A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, et al. The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. Parkinsonism Relat Disord. 2010;16(2):89-95.
27. Muller V, Mohr B, Rosin R, Pulvermüller F, Müller F, Birbaumer N. Short-term effects of behavioral treatment on movement initiation and postural control in Parkinson's disease: a controlled clinical study. Mov Disord. 1997;12(3):306-314. (Pubitemid 27216128)
28. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427-442.
29. Leentjens AF, Verhey FR, Lousberg R, Spitsbergen H, Wilmink FW. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry. 2000;15(7):644-649. (Pubitemid 30608443)
30. Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord. 2006;21(5): 668-672. (Pubitemid 43792748)
31. Chagas MH, Tumas V, Loureiro SR, et al. Validity of a Brazilian version of the Zung self-rating depression scale for screening of depression in patients with Parkinson's disease. Parkinsonism Relat Disord. 2010;16(1):42-45.
32. Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P. The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Behav Neurol. 2006;17(2):109-115. (Pubitemid 44078634)
33. Mondolo F, Jahanshahi M, Grana A, et al. Evaluation of anxiety in Parkinson's disease with some commonly used rating scales. Neurol Sci. 2007;28(5):270-275. (Pubitemid 350055437)
34. Harrison JE, Preston S, Blunt SB. Measuring symptom change in patients with Parkinson's disease. Age Ageing. 2000;29(1):41-45. (Pubitemid 30055062)
35. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972;1(4): 233-238.
36. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol, Neurosurg, Psychiatry. 1992;55(5):377-382.
37. Palanci J, Marsh L, Pontone GM. Gaps in treatment for anxiety in Parkinson Disease. Am J Geriatr Psychiatry. 2011;19(10):907-908.
38. Beck AT, Rush AI, Shaw BF, et al. Cognitive Therapy of Depression. New York, NY: Guilford; 1979.
39. Beck JS. Cognitive Therapy: Basics and Beyond. New York, NY: Guilford; 1995.
40. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. (Pubitemid 9136500)